8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells.

      Cancer research
      Anticarcinogenic Agents, pharmacology, Apoptosis, drug effects, physiology, Bronchi, cytology, Bronchial Diseases, pathology, Cell Line, Tumor, Cells, Cultured, Cyclooxygenase 2 Inhibitors, Drug Screening Assays, Antitumor, Drug Synergism, Epithelial Cells, Fenretinide, Humans, Lung Neoplasms, prevention & control, Mitochondria, Phosphorylation, Precancerous Conditions, Protein Processing, Post-Translational, Proto-Oncogene Proteins c-akt, genetics, Pyrazoles, Recombinant Fusion Proteins, Sulfonamides

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Celecoxib is being evaluated as a chemopreventive agent. However, its mechanism of action is not clear because high doses were used for in vitro studies to obtain antitumor effects. We found that celecoxib inhibited the growth of premalignant and malignant human bronchial epithelial cells with IC(50) values between 8.9 and 32.7 micromol/L, irrespective of cyclooxygenase-2 (COX-2) expression. Normal human bronchial epithelial cells were less sensitive to celecoxib. Because these concentrations were higher than those attainable in vivo (

          Related collections

          Author and article information

          Comments

          Comment on this article